Larimar Therapeutics Financial Overview
Larimar Therapeutics's market cap is currently $296.14M. The company's EPS TTM is $-0.61; its P/E ratio is -1.78; Larimar Therapeutics is scheduled to report earnings on November 5, 2025, and the estimated EPS forecast is $-0.50. See an overview of income statement, balance sheet, and cash flow financials.
